News

Weekly Cannabis Roundup October 8

October 8, 2021 08:00 am ET

New Yorkers can now get their hands on medical cannabis flower, a bipartisan effort to legalize recreational cannabis in Pennsylvania is underway, and New Mexico is breaking ground on a research facility intended to unlock all the mysteries of marijuana.

Let’s dive into this week’s cannanews.


New York’s Cannabis Regulators Approve Medical Flower

New York’s Cannabis Control Board wasted no time in its first meeting on Tuesday, approving sales of medical marijuana (MMJ) flower and other significant changes to the state’s program. Although MMJ has been legal in New York since 2014, only edibles and extracts were available previously. The board also approved MMJ prescriptions written by dentists, podiatrists, and midwives, as well as waived the $50 patient and caregiver registration fee. Additionally, the cannabis limit was increased from a 30-day supply to a 60-day supply.

Pennsylvania Senator Announces Recreational Cannabis Bill

Pennsylvania Sen. Mike Regan announced in a memorandum on Monday that he will be introducing a bill to legalize recreational cannabis in the state, which legalized MMJ in 2016. The former U.S. Marshal voiced the concern that minor cannabis offenses are inundating law enforcement, whereas full cannabis legalization would allow the state to focus on crime associated with deadly drugs like heroin and fentanyl. Considering Regan’s status as a Republican, his move could spearhead a bigger conversation about the partisan divide that so often hinders pro-cannabis legislation. Multiple other Pennsylvania politicians have offered support for the reform.

Exclusive Cannabis Research Facility To Open in New Mexico

Construction has begun on a 115-acre research and manufacturing cannabis plant in Grants, New Mexico—one of just three in the U.S. federally approved to research a Schedule I drug. The company funding the facility, Bright Green Corp., chose the location for its climate. The company’s chairman, Terry Rafih, told media sources that he hoped the facility’s research would play a role in eliminating opioid use. The facility will have more than 100 employees and is worth more than $300 million in investments, according to KOB 4.

Post Your Comments

Z says:

October 8, 2021 at 8:35 am

Excelsior!!!

Reply
Theresa says:

October 8, 2021 at 10:06 am

Before I start let it be known “all”
My Glory Goes to
God my Father
Anyway
I have veen a smoker since my 20’s everyday all day never had a kidney yeast ear urinary infection have never taken antibiotics medications of any kind or hospitalized fir any other reason then giving birth in 81-83 contribute it to
Medical Marijuana and Gods Will

Reply
Carl jase Smith says:

October 8, 2021 at 8:35 pm

Great reviews like to learn more

Reply
Veriheal Banner Ad 1_300 x 250
{"post_type":"post","post_status":"publish","posts_per_page":3,"post__not_in":[18166,4080,15213,15326,15237,16003,20175,19861,19667,19830,19779,18995]}

Latest News

January 11, 2022
Exploring CBN, the Sleepy Cannabinoid

Cannabis contains many cannabinoids that interact with the body’s endocannabinoid system (ECS), which we still have much to learn about. The most…

January 10, 2022
Anti-Drug GOP Sen. Grassley Helps Ayahuasca Church

For over a year, the Iowaska Church of Healing tried and failed to obtain a religious exemption from the IRS in order…

January 10, 2022
A New Study Explores Patient Interest in Medical Cannabis for Breast Cancer

The American Cancer Society estimates that 281,550 women are diagnosed with breast cancer every single year. Of this amount, as many as…